PHISOHEX
LOE ApproachingNDATOPICALEMULSION
Approved
Apr 1949
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PHISOHEX is a topical emulsion small-molecule product approved in 1949 with an unknown mechanism of action and indication profile. This legacy product represents a mature therapeutic asset with limited current clinical development.
LOE Approaching
This legacy product is in lifecycle decline with minimal linked commercial opportunities, suggesting a small or transitioning team structure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PHISOHEX offers limited career advancement; roles focus on operational continuity and managed decline rather than growth. This is a maintenance assignment suited to early-career professionals or those transitioning out of the franchise.
Brand ManagerSupply Chain Specialist
Worked on PHISOHEX at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.